- Drug Pipelines
- January 2022
- 30 Pages
Global
From €455EUR$500USD£390GBP
Lovenox is a brand of hematological drug used to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism (PE). It is an anticoagulant, or blood thinner, that works by preventing the formation of blood clots. Lovenox is a low molecular weight heparin (LMWH) and is administered by subcutaneous injection. It is used in both the prevention and treatment of DVT and PE, and is often used in patients who are at risk for developing these conditions due to surgery, trauma, or other medical conditions.
Lovenox is a widely used hematological drug, and is one of the most commonly prescribed anticoagulants. It is used in both inpatient and outpatient settings, and is often prescribed for long-term use.
Some companies in the Lovenox market include Sanofi, Pfizer, and Bristol-Myers Squibb. Show Less Read more